someone explain telehealth to me like I have not read a paper in years
someone explain telehealth to me like I have not read a paper in years. Searched first, found three threads that contradict each other, hence the post.
Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.
Why "compounded" is not "generic", written out because the confusion is constant.
A generic is an approved product demonstrated to be bioequivalent to a reference. A compounded preparation is made for a patient or, in the case of an outsourcing facility, under a different regulatory route entirely. It carries no equivalence claim and it is not required to demonstrate one.
That is not a quality judgement. Plenty of compounded preparations are made carefully in facilities with real testing programmes. It is a statement about what has and has not been established, and the difference matters when people assume the two are interchangeable.
On concentration, which is where I see people actually get hurt.
A compounded vial can be filled at a different concentration from the branded product you were previously using. If you carry over your old arithmetic — same number of units, different mg/mL — you draw a different amount and may not notice for weeks.
Read the label every time you switch. Redo the arithmetic on paper. Write the concentration on the vial. It is the same habit c/reconstitution keeps preaching and this is the case where it actually bites.
That is everything I have. The rest is opinion and I have tried to keep it out.
best — the order this archive was captured in
A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available.
the shortage list is the whole legal hinge and people skip it
do not assume the concentration matches the branded product
Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.
Same view. If the intake asked you nothing, the intake was a formality and you should factor that in.
Same view.
This is the distinction the whole board runs on. Everything else follows from it.
if a clinic will not name the facility, that is your answer
A 503A pharmacy compounds for an identified patient against a prescription. A 503B outsourcing facility registers with the regulator, may produce without patient-specific prescriptions, and is subject to current good manufacturing practice requirements. The two are governed differently and the difference is not cosmetic.
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.
shortage status changes and the whole arrangement changes with it
ask which facility, then ask for their testing
The five questions worth asking before you commit to any compounded arrangement.
Which facility, by name. Whether it is a 503A pharmacy or a 503B outsourcing facility. What concentration is on the label. What the beyond-use date is based on. Whether there is potency testing on the finished preparation rather than only on the starting material.
All five are answerable in one email and the pattern of what comes back is more informative than any of the individual answers. An organisation with a quality system finds these questions ordinary.
compounded is not generic, there is no equivalence claim
What is the beyond-use date and what is it based on?
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
Careful. Naming a clinic without describing what actually happened turns this into a different kind of thread.
Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.
- 1Same view. If the intake asked you nothing, the intake was a formality and…7 comments in this branch · started by u/discount_math_dm